About
PEGylated Small Molecule
Areas of Focus
Categories
Small Molecule PharmaceuticalVirginia, DC, DE & Maryland
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
693
By Phase
PHASE2: 3PHASE1: 2
By Status
COMPLETED: 4ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06410924Lead Sponsor
A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH
PHASE2Active, not recruiting
67 participants
Started: Jun 13, 2024 · Completed: Jun 30, 2026
NCT04812262Lead Sponsor
A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD
PHASE1Completed
255 participants
Started: Feb 24, 2021 · Completed: Feb 14, 2023
NCT04154072Lead Sponsor
A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease
PHASE2Completed
255 participants
Started: Feb 27, 2020 · Completed: Feb 14, 2023
NCT04159766Lead Sponsor
A Study With NLY01 in Subjects With Type 2 Diabetes
PHASE2Completed
20 participants
Started: Oct 16, 2019 · Completed: Dec 4, 2020
NCT03672604Lead Sponsor
A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects
PHASE1Completed
96 participants
Started: Sep 19, 2018 · Completed: Jul 30, 2019
Locations (1)
Headquarters
Gaithersburg, MD, United States
Map
Loading map...